Liptis improves the lives of people around the world with its outstanding products. And other innovative medicines are on the way. With research and development programs focused on small molecules, and biotechnology, Liptis is exploring more new products for medical conditions such as diabetes, osteoarthritis, musculoskeletal diseases, hypercholesterolemia and sexual dysfunction.
Liptis has a long history of pioneering developments in pharmaceuticals with leading products in the areas of women's health care, musculoskeletal disorder and cardiovascular therapy.
Liptis is also a leader in the development of nutraceuticals.
Liptis's musculoskeletal research developed an important new therapies for patients with joint and bone disorders. Our products include treatments for osteoarthritis that help patients lead more active lives with less pain. In addition, Liptis has a strong presence in the treatment of osteoarthritis, our product Dorofen is one of the best sellers in its category. Liptis scientists are investigating novel treatments for bone and tissue repair, which may impact fracture healing and post-surgical recovery.
Our broad and expanding internal medicine franchise includes cardiovascular and gastrointestinal products. Liptis internal medicine researchers are exploring novel approaches to treat diabetes with our products Glybufen, Diofen, and Glucostat, treat depression with Modostat, treat vascular disorders with Cepress and treat liver diseases with Hepachol.
Liptis has a long history of pioneering developments in pharmaceuticals with leading products in the areas of women's health care, musculoskeletal disorder and cardiovascular therapy.
Liptis was a pioneer in research and development of new products to relieve impotence and sexual dysfunction in men and continues to be at the fore front. Liptis has succeeded to patent the first product of its kind to treat deficiency of libido. Our patented Gentaplex and Aphrofem treatments are the number one choice by doctors
We believe that sound principals of corporate governance are an important key to Liptis' success and its ability to secure the confidence of medical professionals, customers and employees. Good corporate governance starts at the top, both with the management of the Company, and our Board of Directors and the role it takes in overseeing how management serves the long-term interests of Liptis and its shareholders.
The Company always evaluates both the formal and informal corporate governance polices that have been maintained by Liptis for many years.
The Company recognizes, however, that the field of corporate governance is a rapidly evolving and dynamic area. Liptis is committed to good corporate governance and we will continue to seek improvements to our solid foundation in good corporate governance.